1. More Y, D’Cruz AK. Oral Cancer: Review of current management strategies. Natl Med J India. 2013 May-Jun; 26(3):152-8
2. Zimmermann M, Zouhair A, Azria D, Ozsahin M. The epidermal growth factor (EGFR) in head and neck cancer: its role and treatment implications. RadiatOncol. 2006;1:11-15.
3. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown.J Cell Physiol. Mar 2000; 182(3):311-22.
4. Barber BR, Biron VL, Klimowicz AC, Puttagunta L, Côté. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma. Journal of Otolaryngology- Head and Neck Surgery.2013;42:53.
5. Sarkis SA, Abdullah BH, Majeed BA, Nazar G. Biochemical markers EGFR , VEGF, PCNA, P53 and D2-40 in head and neck squamous cell cancers. Head Neck Oncol. 2010; 2: 13.
6. Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J ClinOncol. 2006 Jun 10; 24 (17):2666-72.
7. Smith BD, Smith GL, Carter D. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127:780–785.
8. Smita SB, Radhika MB, Paremala K, Sudhakara M.Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma. J Oral MaxillofacPathol. 2014 May-Aug; 18(2): 169–176
9. Ashraf MJ, Maghbul M, Azarpira N and Khademi B. Expression of Ki-67 and P53 in primary squamous cell carcinoma of the larynx. Indian J PatholMicrobiol. 2010;53 (4):661-5.
10. Gröbe A, Eichhorn W, Fraederich M, Kluwe L, Vashist YJ. Immunohisto-chemical and FISH analysis of EGFRand its prognostic value in patients with oral squamous cell carcinoma . Oral Pathol Med.2014 Mar;43(3):205-10.
11. Lin YT, Chien CY, Lu CT, Lou SD, Lu H, Huang CC. Triple-positive pathologic findings in oral cavity cancer are related to a dismal prognosis. Laryngoscope. 2015 Sep;125(9):E300-5. doi: 10.1002/lary.25463. Epub 2015 Jul 7.
12. Yeh CF, Li WY, Yang MH, Chu PY. Neck observation is appropriate in T1-2, cN0 oral squamous cell carcinoma without perineural invasion or lympho vascularinvasion. Oral Oncol.2014Sep; 50 (9):85762.